Milestone Pharmaceuticals Inc. – Underwriting Agreements

NASDAQ: MIST
Share price (7/7/26): $1.29
Market cap (7/7/26): $161 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from SCHEDULE 13G Underwriting agreement

from SCHEDULE 13G 1 page Joint Filing Agreement

from 8-K 50 pages Milestone Pharmaceuticals Inc. 31,500,000 Common Shares Pre-Funded Warrants to Purchase 3,502,335 Common Shares Series a Warrants to Purchase 35,002,335 Common Shares Series B Warrants to Purchase 35,002,335 Common Shares Underwriting Agreement

from 8-K 32 pages Amended & Restated Open Market Sale Agreementsm

from 8-K 41 pages Milestone Pharmaceuticals Inc. 16,666,667 Common Shares Pre-Funded Warrants to Purchase 3,333,333 Common Shares Underwriting Agreement

from SC 13G/A ~1 page Joint Filing Statement Pursuant to Rule 13d-1

from 8-K 47 pages 3,810,097 Common Shares and Pre-Funded Warrants to Purchase 4,761,903 Common Shares Milestone Pharmaceuticals Inc. Underwriting Agreement

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from SC 13G 2 pages Joint Filing Statement Pursuant to Rule 13d-1

from S-1/A 42 pages Jefferies LLC Cowen and Company, LLC Piper Jaffray & Co. as Representatives of the Several Underwriters